340B Unscripted

Ep 44 | Pharmacotherapy Clinic Services & 340B

In this episode, SpendMend colleague Matt Parker joins Greg and Rob (14:00) to discuss pharmacotherapy services, and how pharmacist-driven care can help promote improved health outcomes in a community, as well as how these services might intersect with a covered entity’s 340B Program. They highlight the clinical and financial benefits that these services can provide, map out a typical workflow for how these services might be executed, and share thoughts on both operational and regulatory challenges that might be encountered when getting started.
In the intro, Rob and Greg briefly discuss some 340B news, including the recently published Administrative Dispute Resolution (ADR) Final Rule.
Register for our webinar on Tuesday, May 14th at 2 PM ET/11 AM PT, which offers pharmacist and pharmacy technician CE credits! https://attendee.gotowebinar.com/register/1001816060425009246?source=340BUnscripted

Ep 43 | Getting to Know the HRSA DRL – DRL 8 Self-Disclosure Documentation and DRL 9 Medicaid Billing Information

In this episode, Greg and Rob continue to provide insights on the HRSA data request list.   DRL #8 is self-disclosure documentation and DRL #9 is Medicaid billing information, which includes providing details regarding your CE’s listing on the Medicaid Exclusion File, as well as sample billing claim forms for physician-administered drugs and billing claim screenshots for retail dispenses.
In the intro, they recap state-level 340B legislation, discuss ongoing uncertainty around Medicare Advantage & Part B underpayment remedies, and also note some recent data published on drug shortages.
Rob and other folks from our team will be attending Asembia in Las Vegas from April 29 – May 2.  Reach out to us if you want to connect there! Email us at 340Unscripted@spendmend.com
Also, save the date for our next webinar, which will be on May 14, 2024 – We’ll be sharing tips on what covered entities should be doing to effectively self-audit their 340B Program operations!

Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 2

SpendMend colleagues Jasmine and Megan continue their conversation providing some grantee CE perspectives concerning the HRSA DRL. 
 

Ep 42 | Getting to Know the HRSA DRL – Grantee Considerations Part 1

In this episode, SpendMend colleagues Jasmine and Megan provide some grantee CE perspectives concerning the HRSA DRL.  They have so much great insight, we are breaking this conversation up into two parts. Stay tuned for Part 2 next week!
In the intro, Rob and Greg discuss thoughts around responding to manufacturer 340B inquiries.

Ep 41 | 340B News & Notes

In this episode, Rob and Greg catch up on a cluster of developments in the 340B space, including updates to manufacturer contract pharmacy restrictions, thoughts on a federal appellate court ruling on Arkansas' contract pharmacy law, a preliminary take on the 340B PATIENTS Act recently introduced by Rep. Doris Matsui (D-CA), and an update on ongoing litigation between hospitals and HRSA over child site eligibility guidance.
Email us at 340BUnscripted@spendmend.com with comments, questions, or topic suggestions!

Ep 40 | Getting to Know the HRSA DRL: DRL 5 Purchasing Documentation and DRL 7 Entity-Owned Pharmacy Documentation

In this episode, Greg and Rob continue reviewing data solicited by HRSA during an audit. DRL #5 is purchasing documentation, including a list of accounts, sample invoices, and 340B purchase order details. This ends up being a labor-intensive section to complete for HRSA, especially for larger organizations with a variety of purchasing practices. DRL #7 is an entity-owned pharmacy documentation, which includes demonstrating ownership of pharmacies that are dispensing 340B drugs but are not registered as contract pharmacies.
In the intro, the guys catch up on new manufacturer restrictions in the contract pharmacy space and share thoughts on other items in the news, including the Change Healthcare cyberattack and a political ad recently published targeting the 340B Program.
 
Contact us at 340BUnscripted@spendmend.com if you have any questions or comments on what we’ve discussed, or have a topic that you think we should address on the podcast!

Ep 39 | A Revisit of Ongoing Contract Pharmacy Restrictions

In this episode, Greg and Rob are once again joined by SpendMend team member Riley Protz, to catch up on the current state of ongoing manufacturer restrictions on 340B contract pharmacy operations, as well as to offer insights on various mitigation strategies, like the opportunity for grantee CEs to make associated site contract pharmacy designations in 340B ESP.
If you have questions about this topic or have other topics that you want us to address on the podcast, email us at 340BUnscripted@spendmend.com.
Pharmacy technicians and Pharmacists looking for CE credits?  Please register to attend our upcoming webinar: https://attendee.gotowebinar.com/register/8340831873822502743?source=340BUnscripted

Ep 38 | Getting to Know the HRSA DRL: DRL 4 Provider List and DRL 6 Contract Pharmacy Documentation

In this episode, Greg and Rob continue their review of items from the HRSA audit data request list (DRL). They’ll cover DRL #4, the provider list, as well as DRL #6, contract pharmacy documentation.  Don’t worry – they’ll come back to DRL #5 (purchasing documentation) in an upcoming episode!
 
In the intro, Rob shares a few insights from the recent 340B Coalition Winter Meeting in San Diego, and then the guys catch up on some 340B related news. They’ll share a quick reminder on grantee 340B annual recertification (starting now through 2/26/2024) and describe communication HRSA has been sending to hospitals that were granted eligibility extensions last year under the Consolidated Appropriations Act. Finally, they’ll discuss some developments from the Senate “Gang of 6” and their newly released 340B legislative draft and request for information on 340B Program reform.